228 results on '"Boirivant M"'
Search Results
2. Nod2 Deficiency in mice is Associated with Microbiota Variation Favouring the Expansion of mucosal CD4+ LAP+ Regulatory Cells
3. P024 Stratification of ulcerative colitis patients according to distinctive tissue cytokine profiles
4. Nod2 Deficiency in mice is Associated with Microbiota Variation Favouring the Expansion of mucosal CD4+LAP+ Regulatory Cells
5. Interferons production by cultured lamina propria mononuclear cells in Crohn’s disease and controls
6. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse
7. Cholera toxin subunit B inhibits IL-12 and IFN-gamma production and signaling in experimental colitis and Crohn's disease
8. Inflammatory bowel disease
9. Oral therapeutic administration of a probiotic mixture suppresses established Th2 responses and systemic anaphylaxis in a murine model of food allergy
10. Serum transforming growth factor β1 during diabetes development in non-obese diabetic mice and humans
11. Cholera toxin subunit B inhibits IL-12 and IFN-γ production and signaling in experimental colitis and Crohn’s disease
12. The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization
13. TGF-β1 production in inflammatory bowel disease: differing production patterns in Crohnʼs disease and ulcerative colitis
14. Postpartum Thyroiditis Is Associated with Fluctuations in Transforming Growth Factor-β1 Serum Levels
15. Deficiency in mice is Associated with Microbiota Variation Favouring the Expansion of mucosal CD4+ LAP+ Regulatory Cells
16. Mucosal Immunoregulation and Inflammatory Bowel Disease: New Insights from Murine Models of Inflammation
17. Interferon-gamma (IFN-γ) can counteract the in vitro inhibitory effect of an HIV p24 immunosuppressive heptapeptide
18. ANTICORPI ANTI PEROSSIDASI TIROIDEA (ABTPO) E TRANSFORMING GROWTH FACTOR BETA1 TGFB1) NELLE TIREOPATIE AUTOIMMUNI
19. Oral probiotic administration induces IL-10 production and prevents autoimmune diabetes in the non-obese-diabetic mouse
20. Oral probiotic administration in the NOD mouse induces systemic and islet IL-10 production and down regulates pancreatic expression of proinflammatory cytokine and chemokines
21. Nod2 deficiency is associated with an increased mucosal immunoregulatory response to commensal microorganisms
22. Oral administration of probiotic compound Vsl#3 prevents the onset of diabetes in NOD mice and is associated to 11-10 up-regulation in gut lymphoid cells
23. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis
24. Computed tomography of bowel wall in patients with Crohn's disease: relationship of infiammatory activity to biological to biological indices
25. COMPUTED-TOMOGRAPHY CAN IDENTIFY DIFFERENT PATTERNS OF BOWEL WALL THICKENING RELATED TO CROHNS-DISEASE ACTIVITY
26. Inflammatory bowel disease
27. Oral therapeutic administration of a probiotic mixture suppresses established Th2 responses and systemic anaphylaxis in a murine model of food allergy
28. Serum angiotensin converting enzyme activity in Crohn's disease and ulcerative colitis
29. Intestinal microflora and immunoregulation
30. TGF-β1 and Smad7 in the regulation of IBD
31. Serum immunomodulatory factors in gastrointestinal diseases. A 30-50-kD serum fraction in Crohn's disease capable of modulating lymphocyte activation
32. Oral sensitization with shrimp tropomyosin induces in mice allergen-specific IgE, T cell response and systemic anaphylactic reactions
33. OC1.04.2 REGULATION OF GUT INFLAMMATION AND TH17 CELL RESPONSE BY INTERLEUKIN-21
34. Addendum
35. Oxazolone-induced colitis: An animal model of ulcerative colitis treatable with antibodies to IL-4.
36. HIV-1 gp 120 accelerates Fas-mediated activation induced human lamina propria T cells apoptosis
37. Lack of immunotoxicity of saquinavir (Ro 31-8959) used alone or in double and triple combination with AZT and DDC
38. Disparate CD4+ Lamina Propria (LP) Lymphokine Secretion Profiles in Inflammatory Bowel Disease
39. Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis.
40. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
41. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients
42. Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation.
43. Transglutaminases in Crohn's disease.
44. 5 DEFINITION OF THE INITIAL IMMUNOLOGICAL MODIFICATIONS,
45. Computed tomography can identify different patterns of bowel wall thickening related to Crohn's disease activity
46. Recently recruited monocyte/macrophages and naive T-cells contribute to submucosal perivascular infiltrates in Crohn's disease (CD)
47. Lamina propria mononuclear cells (LPMC) apoptosis in relation to different activation pathways
48. 105 IMMUNOLOGIC RESPONSES OF HUMAN LAMINA PROPRIA T CELLS (LP T CELLS) IN INFLAMMATORY BOWEL DISEASE (IBD)
49. GLIADIN PEPTIDES (GP) INDUCE RECRUITMENT OF MONONUCLEAR CELLS TO THE SURFACE EPITHELIUM AND OVEREXPRESSION OF ICAM1 AND ICAM3 MOLECULES IN CULTURED TREATED CELIAC MUCOSA
50. Interferon-alpha (IFN-alpha) production by human intestinal mononuclear cells. Response to virus in control subjects and in Crohn's disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.